Adjunctive Silymarin Use May Reduce Disease Activity and Improve Quality of Life in Active RA Patients on DMARD Therapy
Written by Keely Puchalski, ND. Results from this study suggest that adjunctive silymarin supplementation may improve joint symptoms, physical function, fatigue, and mood in patients with active rheumatoid arthritis receiving conventional DMARD therapy, though without significant changes in inflammatory markers CRP or ESR.





